Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Quick Stats
Jan 30, 202662.7
AI Score
BUY1.84
Volume Ratio
Mar 25, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
TYRA Stock Summary
Last updated Jan 30, 2026
TYRA is currently trading at $30.82, positioned above its 200-day moving average of $15.02, indicating a long-term uptrend. The stock has a 52-week range of $6.42 to $32.44.
Technical Analysis: The 50-day moving average stands at $25.38, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 62.995, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.185, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates TYRA at 62.7/100 with a BUY recommendation.
TYRA (Tyra Biosciences, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 62.995 |
| CMF (20) | 0.185 |
| ROC (10) | 6.203 |
| ADX (14) | 44.682 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.825 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -32.143 |
| MFI (14) | 51.907 |
TYRA Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
TYRA Price vs Max Options Open Interest
TYRA Max Change In Options Open Interest
TYRA Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TYRA Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TYRA Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TYRA Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Tyra Biosciences, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
TYRA Moving Averages Analysis
Tyra Biosciences, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Tyra Biosciences, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
TYRA (Tyra Biosciences, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 30.44 |
| 20 | 29.47 |
| 30 | 28.03 |
| 50 | 25.38 |
| 100 | 19.66 |
| 200 | 15.02 |
TYRA Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.7 billion |
| Earnings/Share ($) | -1.88 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.978 |
| EPS Estimate Next Year ($) | -2.2146 |
| WallStreet Target Price ($) | 37.875 |
| Most Recent Quarter |